Back
Corporate News
Senores Pharmaceuticals confirms regulatory compliance for quarter ended September 30, 2026
08-Oct-2026, 02:27
Senores Pharmaceuticals Limited submitted a certificate to the Bombay Stock Exchange and National Stock Exchange on October 8, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as processed by MUFG Intime India Private Limited, formerly Link Intime India Private Limited.
